ZMSR Ltd 13469010 false 2024-07-01 2025-06-30 2025-06-30 The principal activity of the company is general medical practice activities. Digita Accounts Production Advanced 6.30.9574.0 true false 13469010 2024-07-01 2025-06-30 13469010 2025-06-30 13469010 core:RetainedEarningsAccumulatedLosses 2025-06-30 13469010 core:ShareCapital 2025-06-30 13469010 core:CurrentFinancialInstruments core:WithinOneYear 2025-06-30 13469010 bus:SmallEntities 2024-07-01 2025-06-30 13469010 bus:AuditExemptWithAccountantsReport 2024-07-01 2025-06-30 13469010 bus:FullAccounts 2024-07-01 2025-06-30 13469010 bus:SmallCompaniesRegimeForAccounts 2024-07-01 2025-06-30 13469010 bus:RegisteredOffice 2024-07-01 2025-06-30 13469010 bus:Director1 2024-07-01 2025-06-30 13469010 bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 13469010 countries:EnglandWales 2024-07-01 2025-06-30 13469010 2023-07-01 2024-06-30 13469010 2024-06-30 13469010 core:RetainedEarningsAccumulatedLosses 2024-06-30 13469010 core:ShareCapital 2024-06-30 13469010 core:CurrentFinancialInstruments core:WithinOneYear 2024-06-30 iso4217:GBP xbrli:pure

Registration number: 13469010

ZMSR Ltd
Annual Report and Unaudited Filleted Abridged Financial Statements
for the Year Ended 30 June 2025

ZMSR Ltd

Contents

Abridged Balance Sheet | 1
Notes to the Unaudited Abridged Financial Statements | 2

ZMSR Ltd

(Registration number: 13469010)
Abridged Balance Sheet as at 30 June 2025

| Note | 2025 £ | 2024 £
Current assets |  |  |
Cash at bank and in hand |  | 6,988 | 9,588
Creditors: Amounts falling due within one year |  | (2,189) | (3,675)
Net assets |  | 4,799 | 5,913
Capital and reserves |  |  |
Called up share capital |  | 10 | 10
Profit and loss account |  | 4,789 | 5,903
Total equity |  | 4,799 | 5,913

For the financial year ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

| The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
| The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the director on 28 January 2026

Dr Z Mansurah

Director

ZMSR Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 30 June 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Calyx House
South Road
Taunton
Somerset
TA1 3DU

These financial statements were authorised for issue by the director on 28 January 2026.

2 | Accounting policies

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern
These accounts have been prepared on a going concern basis.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 1).